newsfilter
← Latest News
GlobeNewswire·

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market

MELVILLE, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced